Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionMHC class Ib protein binding

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1

2.73e-0816414GO:0023029
GeneOntologyMolecularFunctionimmune receptor activity

KIR3DL3 KIR2DL1 KIR2DL3 KIR2DS5 KIR3DL1 GPR32 GPR32P1

4.11e-08165417GO:0140375
GeneOntologyMolecularFunctionMHC class Ib receptor activity

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1

5.80e-0819414GO:0032394
GeneOntologyMolecularFunctionMHC protein binding

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1

5.99e-0658414GO:0042287
GeneOntologyMolecularFunctionmonoatomic anion transmembrane transporter activity

GPR89A LRRC8A GPR89B LRRC8B SLC4A4

1.39e-05151415GO:0008509
GeneOntologyMolecularFunctionmonoatomic ion transmembrane transporter activity

GPR89A LRRC8A GPR89B ABCC9 LRRC8B PIEZO2 SLC4A4 ZDHHC13 SLC47A2

2.62e-05793419GO:0015075
GeneOntologyMolecularFunctionN-formyl peptide receptor activity

GPR32 GPR32P1

4.10e-055412GO:0004982
GeneOntologyMolecularFunctionmonoatomic anion channel activity

GPR89A LRRC8A GPR89B LRRC8B

5.84e-05103414GO:0005253
GeneOntologyMolecularFunctiontransmembrane transporter activity

GPR89A LRRC8A GPR89B ABCC9 LRRC8B PIEZO2 SLC4A4 ABCD2 ZDHHC13 SLC47A2

1.04e-0411804110GO:0022857
GeneOntologyMolecularFunctionvolume-sensitive anion channel activity

LRRC8A LRRC8B

1.47e-049412GO:0005225
GeneOntologyMolecularFunctiontransporter activity

GPR89A LRRC8A GPR89B ABCC9 LRRC8B PIEZO2 SLC4A4 ABCD2 ZDHHC13 SLC47A2

2.15e-0412894110GO:0005215
GeneOntologyMolecularFunctioninhibitory MHC class I receptor activity

KIR2DS5 KIR3DL1

2.68e-0412412GO:0032396
GeneOntologyMolecularFunctiontransmembrane signaling receptor activity

KIR3DL3 KIR2DS2 ABCC9 KIR2DL1 KIR2DL3 TAS2R38 KIR2DS5 KIR3DL1 GPR32 GPR32P1

3.19e-0413534110GO:0004888
GeneOntologyMolecularFunctionmonoatomic ion channel activity

GPR89A LRRC8A GPR89B ABCC9 LRRC8B PIEZO2

3.25e-04459416GO:0005216
GeneOntologyMolecularFunctioncomplement receptor activity

GPR32 GPR32P1

3.69e-0414412GO:0004875
GeneOntologyMolecularFunctionvoltage-gated monoatomic anion channel activity

GPR89A GPR89B

5.49e-0417412GO:0008308
GeneOntologyMolecularFunctionMHC class I receptor activity

KIR2DS5 KIR3DL1

6.16e-0418412GO:0032393
GeneOntologyMolecularFunctionchannel activity

GPR89A LRRC8A GPR89B ABCC9 LRRC8B PIEZO2

6.60e-04525416GO:0015267
GeneOntologyMolecularFunctionpassive transmembrane transporter activity

GPR89A LRRC8A GPR89B ABCC9 LRRC8B PIEZO2

6.67e-04526416GO:0022803
GeneOntologyMolecularFunctionABC-type transporter activity

ABCC9 ABCD2

4.55e-0349412GO:0140359
GeneOntologyMolecularFunctiongated channel activity

GPR89A GPR89B ABCC9 PIEZO2

4.78e-03334414GO:0022836
GeneOntologyMolecularFunctionvoltage-gated monoatomic ion channel activity

GPR89A GPR89B ABCC9

6.16e-03182413GO:0005244
GeneOntologyMolecularFunctionvoltage-gated channel activity

GPR89A GPR89B ABCC9

6.35e-03184413GO:0022832
GeneOntologyBiologicalProcessmonoatomic anion transmembrane transport

GPR89A LRRC8A GPR89B ABCC9 LRRC8B SLC4A4

5.48e-07153416GO:0098656
GeneOntologyBiologicalProcessmonoatomic anion transport

GPR89A LRRC8A GPR89B ABCC9 LRRC8B SLC4A4

1.56e-06183416GO:0006820
GeneOntologyBiologicalProcessimmune response-regulating signaling pathway

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1 GPR32 GPR32P1

2.62e-06615419GO:0002764
GeneOntologyBiologicalProcessmonoatomic ion transmembrane transport

GPR89A LRRC8A GPR89B ABCC9 LRRC8B PIEZO2 SLC4A4 ZDHHC13 CX3CL1 SLC47A2

4.94e-0511154110GO:0034220
GeneOntologyBiologicalProcesscyclic-GMP-AMP transmembrane import across plasma membrane

LRRC8A LRRC8B

1.07e-048412GO:0140361
GeneOntologyBiologicalProcessguanine nucleotide transmembrane transport

LRRC8A LRRC8B

1.72e-0410412GO:1903790
GeneOntologyBiologicalProcesscyclic nucleotide transport

LRRC8A LRRC8B

2.10e-0411412GO:0070729
GeneOntologyBiologicalProcessguanine nucleotide transport

LRRC8A LRRC8B

2.10e-0411412GO:0001408
GeneOntologyBiologicalProcessregulation of immune response

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1 GPR32 GPR32P1

2.27e-041085419GO:0050776
GeneOntologyBiologicalProcessmonoatomic ion transport

GPR89A LRRC8A GPR89B ABCC9 LRRC8B PIEZO2 SLC4A4 ZDHHC13 CX3CL1 SLC47A2

2.78e-0413744110GO:0006811
GeneOntologyBiologicalProcesstransition between fast and slow fiber

GTF2IRD2 GTF2IRD2B

2.97e-0413412GO:0014883
GeneOntologyBiologicalProcesscomplement receptor mediated signaling pathway

GPR32 GPR32P1

4.55e-0416412GO:0002430
GeneOntologyCellularComponentGolgi-associated vesicle membrane

GPR89A GPR89B ZDHHC13

2.33e-0461413GO:0030660
GeneOntologyCellularComponentearly endosome membrane

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1

7.76e-04212414GO:0031901
GeneOntologyCellularComponentmonoatomic ion channel complex

GPR89A LRRC8A GPR89B ABCC9 LRRC8B

8.26e-04378415GO:0034702
GeneOntologyCellularComponentGolgi-associated vesicle

GPR89A GPR89B ZDHHC13

1.45e-03114413GO:0005798
Domainig

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

1.18e-07190397PF00047
DomainImmunoglobulin

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

1.18e-07190397IPR013151
DomainIG

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

2.32e-05421397SM00409
DomainIg_sub

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

2.32e-05421397IPR003599
Domain-

GTF2IRD2 GTF2IRD2B

2.54e-0543923.90.1460.10
DomainGTF2I

GTF2IRD2 GTF2IRD2B

2.54e-054392IPR004212
DomainGTF2I

GTF2IRD2 GTF2IRD2B

2.54e-054392PS51139
DomainGTF2I

GTF2IRD2 GTF2IRD2B

2.54e-054392PF02946
DomainLRRC8_Pannexin-like

LRRC8A LRRC8B

4.23e-055392IPR021040
DomainPannexin_like

LRRC8A LRRC8B

4.23e-055392PF12534
DomainIG_LIKE

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

6.17e-05491397PS50835
DomainIg-like_dom

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

5.68e-04503396IPR007110
DomainIg-like_fold

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

5.73e-04706397IPR013783
DomainABC_TM1F

ABCC9 ABCD2

1.55e-0328392PS50929
DomainABC1_TM_dom

ABCC9 ABCD2

1.55e-0328392IPR011527
DomainABC_transporter_CS

ABCC9 ABCD2

3.47e-0342392IPR017871
DomainABC_TRANSPORTER_2

ABCC9 ABCD2

4.51e-0348392PS50893
DomainABC_tran

ABCC9 ABCD2

4.51e-0348392PF00005
DomainABC_TRANSPORTER_1

ABCC9 ABCD2

4.70e-0349392PS00211
DomainABC_transporter-like

ABCC9 ABCD2

4.89e-0350392IPR003439
Domainzf-RING_2

SYVN1 RNF145

5.27e-0352392PF13639
DomainRNaseH-like_dom

GTF2IRD2 GTF2IRD2B

9.13e-0369392IPR012337
Domain-

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1

1.18e-026633952.60.40.10
PathwayKEGG_ANTIGEN_PROCESSING_AND_PRESENTATION

KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

2.11e-0888296M16004
PathwayKEGG_GRAFT_VERSUS_HOST_DISEASE

KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1

1.39e-0641294M13519
PathwayREACTOME_DAP12_INTERACTIONS

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1

4.25e-0654294MM14871
PathwayWP_GPCRS_ORPHAN

GPR89A GPR89B GPR137C

7.42e-0619293MM15991
PathwayKEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY

KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

7.93e-06137295M5669
PathwayREACTOME_TRANSPORT_OF_SMALL_MOLECULES

LRRC8A ABCC9 ADCY4 LRRC8B SLC4A4 ABCD2 SLC47A2 SOAT2

8.56e-05736298M27287
PathwayREACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1

1.59e-04135294MM14781
PathwayWP_GPCRS_ODORANT

GPR89A GPR89B TAS2R38 GPR137C

2.83e-04157294MM15872
PathwayKEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY

ADCY4 CX3CL1

5.45e-0417292M47544
PathwayREACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL

KIR2DS2 KIR2DL1 KIR2DL3 KIR3DL1

5.83e-04190294M8240
PathwayREACTOME_MISCELLANEOUS_TRANSPORT_AND_BINDING_EVENTS

LRRC8A LRRC8B

1.19e-0325292MM15172
PathwayREACTOME_MISCELLANEOUS_TRANSPORT_AND_BINDING_EVENTS

LRRC8A LRRC8B

1.29e-0326292M27424
Pubmed

Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

7.54e-181442715896204
Pubmed

Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortion.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

7.54e-181442719875891
Pubmed

KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

1.41e-171542717498266
Pubmed

Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

1.41e-171542719326408
Pubmed

Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

1.41e-171542719926642
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in a Caucasian population of southern Brazil.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

1.41e-171542720082646
Pubmed

Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

1.41e-171542720643584
Pubmed

[Killer cell immunoglobin-like receptor and its ligand gene polymorphisms in Hunan Han patients with type 1 diabetes].

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

1.41e-171542720356536
Pubmed

Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

2.51e-171642719527230
Pubmed

Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

2.51e-171642719897003
Pubmed

Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

2.51e-171642720331834
Pubmed

Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

2.51e-171642720652381
Pubmed

Asian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

2.51e-171642718668235
Pubmed

[Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population].

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

2.51e-171642716403292
Pubmed

Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

2.51e-171642719279038
Pubmed

No association of KIR genes with Behcet's disease.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

2.51e-171642717868255
Pubmed

A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

2.51e-171642718643961
Pubmed

Distribution of killer cell immunoglobulin-like receptor (KIR) genotypes in patients with familial Mediterranean fever.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

2.51e-171642719309280
Pubmed

Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Java, Kalimantan, Timor and Irian Jaya.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

2.51e-171642719000141
Pubmed

Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Sumatra, Sulawesi and Moluccas Islands.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

2.51e-171642720670355
Pubmed

HLA-DQA1*0505 sharing and killer immunoglobulin-like receptors in sub fertile couples: report from the 15th International Histocompatibility Workshop.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

2.51e-171642720210919
Pubmed

KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

4.26e-171742719169284
Pubmed

The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

4.26e-171742720173792
Pubmed

Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

4.26e-171742720878400
Pubmed

[Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese].

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

4.26e-171742719218127
Pubmed

Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

4.26e-171742720483367
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in the Tibetan ethnic minority group of China.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

4.26e-171742720650299
Pubmed

Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

4.26e-171742719450876
Pubmed

[Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

4.26e-171742719968064
Pubmed

Distribution of killer-cell immunoglobulin-like receptor genes in Eastern mainland Chinese Han and Taiwanese Han populations.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

4.26e-171742719761533
Pubmed

Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

6.97e-171842719630074
Pubmed

Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

6.97e-171842720519398
Pubmed

Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

6.97e-171842720200544
Pubmed

Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

6.97e-171842720580654
Pubmed

Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

6.97e-171842719046302
Pubmed

Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

6.97e-171842719846535
Pubmed

Distribution of killer cell immunoglobulin-like receptor genes in the mestizo population from Venezuela.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

6.97e-171842720210918
Pubmed

Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

1.10e-161942718778326
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in a Southern Brazilian population from the state of Paraná.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

1.10e-161942718848853
Pubmed

KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

1.10e-161942718571006
Pubmed

Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

1.10e-161942720600442
Pubmed

Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

1.69e-162042720193031
Pubmed

Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

1.79e-1694267749980
Pubmed

Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

2.54e-162142719861144
Pubmed

Distribution of KIR genes in the population of unrelated individuals homozygous for ancestral haplotype AH8.1 (HLA-A1B8DR3).

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

3.72e-162242720492596
Pubmed

Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

4.47e-161042612559621
Pubmed

Natural killer cells and immune surveillance.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

9.82e-161142618830515
Pubmed

[Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

9.82e-161142619664392
Pubmed

Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

1.96e-151242619936734
Pubmed

Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

1.96e-151242619181658
Pubmed

Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

1.96e-151242620371502
Pubmed

[Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia].

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS5 KIR3DL1

1.96e-151242617490516
Pubmed

Immunogenetic characteristics of patients with autoimmune gastritis.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

3.38e-152942720082482
Pubmed

[Study on the polymorphism of killer cell immunoglobulin like receptor (KIR) gene with systemic lupus erythematosus of North population in China].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

3.64e-151342618687225
Pubmed

KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

3.64e-151342619934297
Pubmed

Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

3.64e-151342619120281
Pubmed

[Genotype and haplotype analysis of killer cell immunoglobulin-like receptors in ankylosing spondylitis].

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1

6.37e-151442619489269
Pubmed

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS5 KIR3DL1

6.37e-151442618945962
Pubmed

Multiple sclerosis associates with LILRA3 deletion in Spanish patients.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

6.37e-151442619421224
Pubmed

Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathy.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

1.06e-141542619850842
Pubmed

Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

1.06e-141542620207982
Pubmed

Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

1.06e-141542619493232
Pubmed

Role of human leukocyte antigen, killer-cell immunoglobulin-like receptors, and cytokine gene polymorphisms in leptospirosis.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

1.45e-143542719683555
Pubmed

Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation.

KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

2.62e-141742619032228
Pubmed

The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5

2.62e-141742620173784
Pubmed

Activation of a subset of human NK cells upon contact with Plasmodium falciparum-infected erythrocytes.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS5 KIR3DL1

4.21e-14742514607943
Pubmed

HLA and KIR frequencies in Sicilian Centenarians.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS5 KIR3DL1

8.17e-142042620426625
Pubmed

NullHap--a versatile application to estimate haplotype frequencies from unphased genotypes in the presence of null alleles.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5

1.12e-13842518681957
Pubmed

A population-based cohort study of KIR genes and genotypes in relation to cervical intraepithelial neoplasia.

KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1

1.12e-13842515730517
Pubmed

Alternatively spliced forms of human killer inhibitory receptors.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

2.52e-1394258662091
Pubmed

[Relationship between CMV reactivation and KIR haplotype/HLA-Cw genotype in patients after unrelated-donor hematopoietic stem cell transplantation.].

KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS5 KIR3DL1

1.58e-121242520137308
Pubmed

[Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation].

KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1

1.84e-12442418269867
Pubmed

Activating killer cell immunoglobulin-like receptor gene KIR2DS1 is associated with psoriatic arthritis.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3

9.17e-12542416112031
Pubmed

Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells.

KIR2DS2 KIR2DL1 KIR2DL3 KIR3DL1

9.17e-1254247716543
Pubmed

Association of killer cell immunoglobulin-like receptor genotypes with vascular arterial events and anticardiolipin antibodies in patients with lupus.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3

9.17e-12542418755860
Pubmed

Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3

6.41e-11742411169255
Pubmed

Identification of the mouse killer immunoglobulin-like receptor-like (Kirl) gene family mapping to chromosome X.

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1

6.41e-11742412618911
Pubmed

Expression of a killer cell receptor-like gene in plastic regions of the central nervous system.

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1

6.41e-11742415748957
Pubmed

Genotypes of NK cell KIR receptors, their ligands, and Fcγ receptors in the response of neuroblastoma patients to Hu14.18-IL2 immunotherapy.

KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1

1.28e-10842420935224
Pubmed

KIR haplotype content at the allele level in 77 Northern Irish families.

KIR2DS2 KIR2DL2 KIR2DL3 KIR3DL1

1.28e-10842417200871
Pubmed

Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus.

KIR3DL3 KIR2DL2 KIR2DS5 KIR3DL1

3.84e-101042421206914
Pubmed

Killer Immunoglobulin-Like Receptor 2DS2 (KIR2DS2), KIR2DL2-HLA-C1, and KIR2DL3 as Genetic Markers for Stratifying the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients.

KIR2DS2 KIR2DL2 KIR2DL3

1.64e-09342330696053
Pubmed

Associations of killer cell immunoglobulin- like receptor genes with rheumatoid arthritis.

KIR2DS2 KIR2DL2 KIR2DL3

1.64e-09342322960345
Pubmed

Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors.

KIR2DL1 KIR2DL2 KIR2DL3

1.64e-09342315879158
Pubmed

Differential contribution of education through KIR2DL1, KIR2DL3, and KIR3DL1 to antibody-dependent (AD) NK cell activation and ADCC.

KIR2DL1 KIR2DL3 KIR3DL1

1.64e-09342330698860
Pubmed

Imputation of KIR Types from SNP Variation Data.

KIR2DS2 KIR2DL2 KIR2DL3

1.64e-09342326430804
Pubmed

[Effect of demethylation treatment on the expression of inhibitory receptor KIR gene in NK-92MI cell line].

KIR2DL1 KIR2DL2 KIR2DL3

1.64e-09342319549382
Pubmed

Cutting edge: selective expression of inhibitory or activating killer cell Ig-like receptors in circulating CD4+ T lymphocytes.

KIR2DS2 KIR2DL2 KIR2DL3

1.64e-09342318292496
Pubmed

High-throughput genotyping of KIR2DL2/L3, KIR3DL1/S1, and their HLA class I ligands using real-time PCR.

KIR2DL2 KIR2DL3 KIR3DL1

6.54e-09442319522772
Pubmed

B-lymphoma cells escape rituximab-triggered elimination by NK cells through increased HLA class I expression.

KIR2DL1 KIR2DL2 KIR2DL3

6.54e-09442320056126
Pubmed

[Analysis of HLA-Cw, KIR2D genetic variations in 2 Chinese populations].

KIR2DL1 KIR2DL2 KIR2DL3

6.54e-09442318543232
Pubmed

NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts.

KIR2DL1 KIR2DL3 KIR3DL1

6.54e-09442327732638
Pubmed

Investigation of activating and inhibitory killer cell immunoglobulin-like receptors and their putative ligands in type 1 diabetes (T1D).

KIR2DL1 KIR2DL2 KIR2DL3

6.54e-09442326542066
Pubmed

Killer Ig-like receptor (KIR) genotype and HLA ligand combinations in ulcerative colitis susceptibility.

KIR2DS2 KIR2DL2 KIR2DL3

6.54e-09442316929347
Pubmed

Genetic interactions of KIR and G1M immunoglobulin allotypes differ in obese from non-obese individuals with type 2 diabetes.

KIR2DL1 KIR2DL3 KIR3DL1

6.54e-09442318632158
Pubmed

Study of the KIR gene profiles and analysis of the phylogenetic relationships of Rajbanshi population of West Bengal, India.

KIR2DL1 KIR2DL3 KIR3DL1

6.54e-09442323354323
Pubmed

HLA-C and KIR genes in hepatitis C virus infection.

KIR2DL1 KIR2DL2 KIR2DL3

6.54e-09442316571411
Pubmed

KIR/HLA ligand incompatibility in kidney transplantation.

KIR2DS2 KIR2DL2 KIR2DL3

6.54e-09442318091530
Pubmed

Oligoclonal band phenotypes in MS differ in their HLA class II association, while specific KIR ligands at HLA class I show association to MS in general.

KIR2DL1 KIR2DL2 KIR2DL3

6.54e-09442325037176
Pubmed

Diversity of the repertoire of p58 killer cell inhibitory receptors in a single individual.

KIR2DS2 KIR2DL1 KIR2DL3

1.63e-08542310424431
InteractionKIR3DL1 interactions

KIR2DS2 KIR2DL1 KIR2DL2 KIR3DL1

8.45e-0913394int:KIR3DL1
InteractionKIR2DL2 interactions

KIR2DS2 KIR2DL1 KIR2DL2 KIR3DL1

8.45e-0913394int:KIR2DL2
InteractionKIR3DP1 interactions

KIR2DS2 KIR2DL1 KIR2DS5

2.68e-084393int:KIR3DP1
InteractionKIR2DS3 interactions

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS5

5.67e-0820394int:KIR2DS3
InteractionKIR2DS2 interactions

KIR2DS2 KIR2DL2 KIR2DS5 KIR3DL1

7.55e-0737394int:KIR2DS2
InteractionKIR2DS5 interactions

KIR3DL3 KIR2DS2 KIR2DS5

3.69e-0616393int:KIR2DS5
InteractionKIR2DL1 interactions

KIR2DL1 KIR2DL2 KIR3DL1

2.12e-0528393int:KIR2DL1
InteractionLRRC8B interactions

LRRC8A LRRC8B PDE3B

3.51e-0533393int:LRRC8B
InteractionIPPK interactions

GPR89A LRRC8A ZDHHC13 CERS4

7.34e-05116394int:IPPK
InteractionASGR1 interactions

HIVEP1 KIR2DL3 SYVN1

2.12e-0460393int:ASGR1
InteractionGTF2IRD2 interactions

GTF2IRD2 GTF2IRD2B

2.38e-0412392int:GTF2IRD2
InteractionTTYH1 interactions

GPR89A LRRC8A LRRC8B PDE3B CERS4

2.69e-04300395int:TTYH1
InteractionRABL3 interactions

GPR89A GPR89B SYVN1 CERS4

2.78e-04164394int:RABL3
InteractionGTF2IRD2B interactions

GTF2IRD2 GTF2IRD2B

3.77e-0415392int:GTF2IRD2B
Cytoband19q13.4

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

1.07e-107942619q13.4
CytobandEnsembl 112 genes in cytogenetic band chr19q13

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1 GPR32 GPR32P1

7.14e-041192426chr19q13
Cytoband11p15.1

PDE3B ZDHHC13

1.40e-036042211p15.1
Cytoband1q21.1

GPR89A GPR89B

1.49e-03624221q21.1
Cytoband7q11.23

GTF2IRD2 GTF2IRD2B

3.60e-03974227q11.23
Cytoband19q13.33

GPR32 GPR32P1

4.28e-0310642219q13.33
Cytoband8q24.3

NRBP2 MROH5

4.85e-031134228q24.3
GeneFamilyCD molecules|Killer cell immunoglobulin like receptors

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

3.92e-1618297620
GeneFamilyADAM metallopeptidase domain containing|CD molecules

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

2.28e-06394297471
GeneFamilyVolume regulated anion channel subunits

LRRC8A LRRC8B

2.48e-0552921158
CoexpressionKAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_NEGATIVE

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

9.07e-1349407M40909
CoexpressionGSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_DN

KIR3DL3 KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

4.19e-07190406M4662
CoexpressionHE_LIM_SUN_FETAL_LUNG_C4_CD16_POS_NK_CELL

KIR2DL1 KIR2DL3 KIR3DL1

2.64e-0618403M45763
CoexpressionGSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_DN

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5

1.27e-05199405M9885
CoexpressionUNTERMAN_IPF_VS_CTRL_NK_CELL_DN

KIR2DL1 KIR3DL1

1.01e-0410402M48288
ToppCell10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|lymph-node_spleen / Manually curated celltypes from each tissue

KIR3DL3 KIR2DL1 KIR2DL3 SLC4A4 KIR3DL1

6.70e-07191395f802a4686ecf00e8302047bfe23356f24b266cf8
ToppCellCaecum-T_cell-gd_T|Caecum / Region, Cell class and subclass

KIR3DL3 PDE3B KIR2DL1 KIR2DL3 KIR3DL1

8.41e-07200395eaacd14b6d4a1c7d52deab110ed3a6c7d3dc1f8e
ToppCellCaecum-(1)_T_cell-(17)_gd_T|Caecum / shred on region, Cell_type, and subtype

KIR3DL3 PDE3B KIR2DL1 KIR2DL3 KIR3DL1

8.41e-072003952aaa6b37e9f8d95de53f284a42a3ac14e6351b40
ToppCell(17)_gd_T|World / shred on Cell_type and subtype

KIR3DL3 PDE3B KIR2DL1 KIR2DL3 KIR3DL1

8.62e-072013957fcfe48758acf07cb3dda939ce589ae1518e41c9
ToppCell368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|368C / Donor, Lineage, Cell class and subclass (all cells)

KIR2DL1 KIR2DL3 KIR3DL1 ZDHHC13

8.23e-061473943ed5b020ce1f1277917d79ef1f7da53fa474e8db
ToppCell368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

KIR2DL1 KIR2DL3 KIR3DL1 ZDHHC13

9.89e-06154394ba55a63cfa5e0fb9dfec794f80078a2f0d03d0ad
ToppCell10x5'-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|GI_small-bowel / Manually curated celltypes from each tissue

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1

1.01e-051553941c67f58ed79331addbc012dab0cb09a7f350aedb
ToppCell367C-Lymphocytic-NK_cells-NK_cell_C|367C / Donor, Lineage, Cell class and subclass (all cells)

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1

1.04e-05156394a1b9e7621b646d354c2ccd850ce6a4fa9ff8a026
ToppCellFLU-Healthy-1|Healthy / Virus stimulation, Condition and Cluster

GTF2IRD2 KIR2DL1 KIR2DL2 KIR3DL1

1.12e-0515939497c8e16a7ac10ebba96daee97f9fb1d4a404f23b
ToppCellFLU-Healthy-1|FLU / Virus stimulation, Condition and Cluster

GTF2IRD2 KIR2DL1 KIR2DL2 KIR3DL1

1.12e-05159394fe2a9f79b058e89214256e736f6e266830cdfa28
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

KIR2DL1 KIR2DL3 SLC4A4 KIR3DL1

1.39e-05168394240ea32b64d86f9216785010d6b237d9adf052c9
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

KIR2DL1 KIR2DL3 SLC4A4 KIR3DL1

1.39e-05168394b4bb03efb601a61465260f93896c56861c588bef
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

KIR2DL1 KIR2DL3 SLC4A4 KIR3DL1

1.43e-05169394e7470a5b060881b2a8ce2ab04b0788396aa13889
ToppCellNS-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1

1.49e-05171394adda76991d9b150bb8ccf3989b7cbbf41843cf0b
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

KIR2DL1 KIR2DL3 SLC4A4 KIR3DL1

1.53e-05172394e3a8891694343b6b01e80a200ae338d24797e417
ToppCell5'-Adult-LymphNode-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1

1.56e-0517339479d11f94a8f6a420c18c2fef0da77e9af3204765
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

KIR2DL1 KIR2DL3 SLC4A4 KIR3DL1

1.64e-051753948fb8c4b9e2d9b7d737f59cd9bd3dc2bca5a8dfc4
ToppCellwk_15-18-Hematologic_Lymphocytic-NK-Activated_NK|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1

1.67e-051763946802ed40eb0f91674d4f0120a3d4888c8a2e9612
ToppCell10x5'v1-week_17-19-Lymphocytic_NK-T_NK-mature_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

KIR2DL1 KIR2DL3 SLC4A4 KIR3DL1

1.71e-051773940f2616a81f8fbede77c860b2126e3fa826672da3
ToppCell10x3'2.3-week_17-19-Lymphocytic_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1

1.83e-051803941c8398342d3fa4d5ca9a8a63626cc497c5291446
ToppCell10x3'2.3-week_17-19-Lymphocytic_NK-T_NK-CD56_bright_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1

1.83e-05180394ddbab26b05f057bd78b78773381cd447bd2e2726
ToppCell10x3'2.3-week_17-19-Lymphocytic_NK-T_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1

1.83e-051803940a98d21fec67a890e75ebf0e2d23adddd77da214
ToppCell3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PCNX2 KIR2DL1 KIR2DL3 KIR3DL1

1.87e-05181394e4dbc09f0210de465d8347969b301c22463a2b7d
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group

PDE3B HIVEP1 ITGB6 SLC47A2

1.99e-05184394d2bf0135eb56bb410997dccea39c5ede88a0617f
ToppCell10x5'v1-week_12-13-Lymphocytic_NK-T_NK-mature_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

KIR2DL1 KIR2DL3 SLC4A4 KIR3DL1

2.08e-05186394165d02be3b3eaeb8784a2b0b2020928b21a19bc7
ToppCell10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-CD56_bright_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1

2.17e-051883940a2be6eac6fde669fbc58fd1b2e93e4acf17ddde
ToppCell(1)_T_CD8_gd|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)

KIR3DL3 KIR2DL1 SLC4A4 KIR3DL1

2.21e-0518939462eda4bcfd21d5025ac676d524994ede22721c1d
ToppCell10x3'2.3-week_12-13-Lymphocytic_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1

2.21e-05189394723c57f278919e8251d56b3d19411f9088319450
ToppCell10x3'2.3-week_12-13-Lymphocytic_NK-T_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1

2.21e-05189394960374f5fb278659500a7c948c3068a95dd62eb0
ToppCell(1)_T_cells-(1)_T_CD8_gd|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)

KIR3DL3 KIR2DL1 SLC4A4 KIR3DL1

2.26e-05190394268772d2adff34f7175b8474e95b67fd96dc1234
ToppCell10x5'v1-week_17-19-Lymphocytic_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

KIR2DL1 KIR2DL3 SLC4A4 KIR3DL1

2.35e-0519239463e815664b228575886396387d2738cd73855759
ToppCell10x5'v1-week_14-16-Lymphocytic_NK-T_NK-mature_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1

2.35e-05192394e48bbcb97c113f323ad4db96bd10d593b9206923
ToppCell10x_5'_v1-Non-neoplastic-Lymphoid-NK|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ADCY4 KIR2DL3 KIR3DL1 SOAT2

2.35e-05192394930319cbd82b9e54864147ffcdc8bd0ea7b937be
ToppCell10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo|lymph-node_spleen / Manually curated celltypes from each tissue

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1

2.35e-051923944d72b9264ed62e0c08cde4078061b348253f6989
ToppCell10x_5'_v1-Non-neoplastic-Lymphoid-NK-NK|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ADCY4 KIR2DL3 KIR3DL1 SOAT2

2.35e-05192394c7bcebcb88a25b2c97d798120efa9d5958e7f798
ToppCell10x5'v1-week_17-19-Lymphocytic_NK-T_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

KIR2DL1 KIR2DL3 SLC4A4 KIR3DL1

2.35e-05192394095151a4f878944835945f698aa0e3b540ffc8c3
ToppCellTracheal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1

2.40e-0519339491a1c9b8390cbd881db8c49d8f34feca0d1067d6
ToppCellMild_COVID-19-T/NK-NK|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）

KIR2DL1 KIR2DL3 KIR3DL1 CERS4

2.40e-051933949c455d9d845fa230e9a61d9a5f9d6a2ccf5d7350
ToppCellICU-SEP-Lymphocyte-T_NK-NK|ICU-SEP / Disease, Lineage and Cell Type

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1

2.40e-05193394f110f86db305e41639087f5b1a2dff103c07adf0
ToppCellLeuk-UTI-Lymphocyte-T_NK-NK|Leuk-UTI / Disease, Lineage and Cell Type

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1

2.45e-0519439436afc4e48d267be3b8aa1e33fad043bcd54c6bc5
ToppCell10x5'v1-week_12-13-Lymphocytic_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

KIR2DL1 KIR2DL3 SLC4A4 KIR3DL1

2.45e-051943945afe7f48d3383f3dac18765f97999c8b6936dc1b
ToppCellfacs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADCY4 LRRC8B PIEZO2 CX3CL1

2.45e-05194394f159ef8541d75a4e98468947f231bb463bec922c
ToppCell367C-Lymphocytic-NK_cells|367C / Donor, Lineage, Cell class and subclass (all cells)

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1

2.45e-051943942e447de50b3f4b59e3b9928df83879955fed93cc
ToppCell10x5'v1-week_12-13-Lymphocytic_NK-T_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

KIR2DL1 KIR2DL3 SLC4A4 KIR3DL1

2.45e-05194394ec7e0ca6c9a2f63938e06ee771da09eff14fc3b5
ToppCellIIF-Lymphocyte-T_NK-NK|IIF / Disease, Lineage and Cell Type

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1

2.50e-05195394464ce05cb52f78aee22d3baa6641b37bd53aae16
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

KIR2DL1 KIR2DL3 SLC4A4 KIR3DL1

2.50e-0519539498b02beafe1d418442e41f85cbf0c7b194fe5957
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

KIR2DL1 KIR2DL3 SLC4A4 KIR3DL1

2.50e-051953949ecae6c26a0d0607d101ccf1c38f0b23c5a256a8
ToppCellBL-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1

2.55e-05196394cfbeaabbeeb197f0cf8240a752d1f2995d59d7b7
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

KIR2DL1 KIR2DL3 SLC4A4 KIR3DL1

2.55e-051963949b3848dd4256cd6d9a21ef6bfdbd0cb7c0030005
ToppCellAT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id

SLC4A4 RNF145 CX3CL1 ITGB6

2.60e-051973945e0d222872a25bb9e9069d3dffda2844bb69874a
ToppCellURO-Lymphocyte-T_NK-NK|URO / Disease, Lineage and Cell Type

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1

2.65e-051983942ccff882aafabf041df15b31d9abc50dcbc2696e
ToppCellTracheal-10x5prime-Immune_Lymphocytic-NK-ILC|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

PDE3B KIR2DL1 KIR2DL3 KIR3DL1

2.76e-0520039444674ccfd1ad4ac45968484d70220bc0506e2651
ToppCellBiopsy_Control_(H.)-Immune-NK_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1

2.76e-05200394c93393d52ed1c238d539f254fd2a95eb101a6f65
ToppCellTracheal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

PDE3B KIR2DL1 KIR2DL3 KIR3DL1

2.76e-0520039472e1cc0b222df3ab76164524676e91628e237995
ToppCellTracheal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

PDE3B KIR2DL1 KIR2DL3 KIR3DL1

2.76e-05200394b5d00efb4286ae63cb081ef774aa0b0ff90d6c8a
ToppCell(00)_NK|World / shred on Cell_type and subtype

KIR2DL1 KIR2DL3 SLC4A4 KIR3DL1

2.87e-05202394da1667a138a1195bd5fc9281495dd10e73066843
ToppCell368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)

KIR2DL1 KIR2DL3 ZDHHC13

1.35e-04114393670c9802a59b39241abf6f2c12a3d1844c7db5e5
ToppCellTCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Mucinous_Adenocarcinoma-8|TCGA-Lung / Sample_Type by Project: Shred V9

KIR3DL3 KIR2DL3 KIR3DL1

1.39e-0411539355a56828f86c004cd11d1a426a03e86246e949a3
ToppCell368C-Lymphocytic-NK_cells-NK_cell_A|368C / Donor, Lineage, Cell class and subclass (all cells)

KIR2DL1 KIR2DL3 KIR3DL1

2.81e-041463930e38e1fa40b1fcd1bb61f7af7cc2206846c192ae
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PDE3B SLC4A4 GPR137C

2.86e-041473932885978bcfc5623967c0c1204dadf5c78c74a082
ToppCell368C-Lymphocytic-NK_cells|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

KIR2DL1 KIR2DL3 KIR3DL1

3.04e-0415039317b3ac5ddc47b9cba0a27b268d63a6e491b2b111
ToppCell368C-Lymphocytic-CD8+_Cytotoxic_T-cell|368C / Donor, Lineage, Cell class and subclass (all cells)

KIR2DL1 KIR2DL3 KIR3DL1

3.10e-04151393512f7f37ddc8dfa1906f7fff92b571929236c9ea
ToppCellE18.5-samps-Mesenchymal-Pericyte-pericyte_B|E18.5-samps / Age Group, Lineage, Cell class and subclass

ABCC9 PDE3B GPR137C

3.10e-041513938ba15ab24fe2e71df0a2a7511ca451ad2376bd91
ToppCell367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|367C / Donor, Lineage, Cell class and subclass (all cells)

KIR2DL1 KIR2DL3 FSCN3

3.28e-04154393a39877cdf7b441b5c953f744ed30f1d5acf4ea19
ToppCell367C-Lymphocytic-NK_cells-NK_cell_C|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

KIR3DL3 KIR2DL1 KIR2DL3

3.41e-04156393e6798d2b9c2c1fc6525c24f596f25aa85a375651
ToppCell368C-Lymphocytic-NK_cells|368C / Donor, Lineage, Cell class and subclass (all cells)

KIR2DL1 KIR2DL3 KIR3DL1

3.47e-04157393ef5c0ace4cd500b6cc50fb7076298f3d3543b40c
ToppCell367C-Lymphocytic-NK_cells-NK_cell_B|367C / Donor, Lineage, Cell class and subclass (all cells)

KIR2DL1 KIR2DL3 KIR3DL1

3.74e-04161393f7dc1e3326ab22f2eb1e94b632469a0682a3289c
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

KIR2DL1 KIR2DL3 KIR3DL1

3.88e-04163393466c8129852a5b16cd9fcc6b79e799abc21bb21a
ToppCell390C-Lymphocytic-NK_cells-NK_cell_B2|390C / Donor, Lineage, Cell class and subclass (all cells)

KIR3DL3 KIR2DL3 KIR3DL1

3.88e-04163393036e65de0f8fc391f3e4d299bf4c05ee5c3b5a37
ToppCell5'-Adult-SmallIntestine-Hematopoietic-T_cells-TRGV4_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

KIR3DL3 KIR2DL1 KIR2DL3

3.88e-0416339311cc18f36604d9a5f4e7fb8626a8f0fb141da5e1
ToppCell343B-Lymphocytic-ILC|343B / Donor, Lineage, Cell class and subclass (all cells)

PCNX2 LRRC8B PDE3B

4.09e-04166393a54377c703efff42d2cc1a8fdb610facc58053dd
ToppCell5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SLC4A4 CX3CL1 CERS4

4.09e-041663939e98e6070055bfc780becee52d77830e06b6d854
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

KIR3DL3 KIR2DL1 KIR2DL3

4.23e-04168393696b31bedbc7d40817a733e8c6ec2633404be619
ToppCell367C-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

NRBP2 KIR2DL1 KIR2DL3

4.23e-0416839380233a13135fd159f5764336a1fe67fba237776b
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

KIR2DL1 KIR2DL3 KIR3DL1

4.31e-04169393a3234904d7ff8f451ca894e93badd61d75e3cd2a
ToppCellASK454-Immune-NK_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq

KIR2DL1 KIR2DL2 KIR3DL1

4.38e-0417039384705434234bf2fbb5256bd5a1f6ab54c01c5a51
ToppCell367C-Lymphocytic-NK_cells-Proliferating_NK_cell|367C / Donor, Lineage, Cell class and subclass (all cells)

KIR3DL3 KIR2DL3 KIR3DL1

4.46e-041713934ede6e916e593f208f2f8ccf82ef2335e061fc86
ToppCell3'-Distal_airway-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SLC4A4 RNF145 ITGB6

4.46e-04171393d5960b40ad5b87aaa00c93a6b31cdf41cc4f1375
ToppCell3'-Distal_airway-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SLC4A4 RNF145 ITGB6

4.46e-04171393fd59ac4a39748840b2ee1c930ea475433ff61485
ToppCell3'-Distal_airway-Epithelial-Epithelial_transtional-epithelial_cell_of_lung|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SLC4A4 RNF145 ITGB6

4.46e-04171393d382430e5cdd0f2aac4fc093d8fe8d66efb4629b
ToppCell3'-Distal_airway-Epithelial-Epithelial_transtional|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SLC4A4 RNF145 ITGB6

4.46e-041713934347e6f62c04ea43299893ad4b79719049009a56
ToppCellASK454-Immune-NK_cell|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq

KIR2DL1 KIR2DL2 KIR3DL1

4.53e-04172393c9e738c3540ee09b08805b1cdb66b4a0d9d40d33
ToppCell367C-Lymphocytic-NK_cells-NK_cell_D|367C / Donor, Lineage, Cell class and subclass (all cells)

KIR2DL1 KIR2DL3 KIR3DL1

4.53e-041723936379ae0aca9007c3a8a87e3330908fc90961ad3f
ToppCell3'_v3-GI_small-bowel-Lymphocytic_NK-NK_CD16|GI_small-bowel / Manually curated celltypes from each tissue

KIR2DL1 KIR2DL3 KIR3DL1

4.53e-04172393701de463f85aaad3a4b36a0d5fbc416406620089
ToppCell15-Trachea-Immune-Hematopoietic,_Natural_Killer_Cell|Trachea / Age, Tissue, Lineage and Cell class

GPR89B KIR2DL2 KIR2DL3

4.61e-041733936884af1492e8a3bb92a33303d4d5ec3343e88b00
ToppCellChildren_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

SLC4A4 CX3CL1 CERS4

4.61e-04173393464267a2ff3f5c387b6c9c6fa4dab135a221f448
ToppCellPND01-03-samps-Endothelial-Postnatal_endothelial-endothelial_cells_D|PND01-03-samps / Age Group, Lineage, Cell class and subclass

ADCY4 PIEZO2 CX3CL1

4.69e-04174393b4f3f5334803e5903bc496decf923f2e44f7fa3c
ToppCellASK452-Immune-NK_cell|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq

KIR2DL1 KIR2DL2 KIR3DL1

4.69e-04174393b84e6dc1c003a677234ce3a818650ff58a45dd09
ToppCellCOVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type

GPR89B SLC4A4 ITGB6

4.85e-0417639336f77d878a53b30465b0dea8333a3865dba75613
ToppCell3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

KIR2DL1 KIR2DL3 KIR3DL1

4.85e-04176393ce85a13e10cf37f5cf38ca8b0bac6701b6d00ffd
ToppCell3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-NK_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

KIR2DL1 KIR2DL3 KIR3DL1

4.93e-04177393fcdd71e2a727ae24b726a39216ea02c06df1f593
ToppCellfacs-Skin-Anagen-3m-Lymphocytic-T_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PDE3B SLC4A4 KIR3DL1

4.93e-041773937853430fb0d1a18d835e8956777e0616c5d7d412
ToppCellnucseq-Epithelial-Epithelial_Airway-Secretory/RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

SLC4A4 CX3CL1 CERS4

4.93e-04177393779ba86f53650772755b52460be03f18bb204e55
ToppCellnucseq-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

SLC4A4 CX3CL1 CERS4

4.93e-041773930f210cfb61b873c5fd77dc17eadf4d017306500e
ToppCellfacs-Skin-Anagen-3m-Lymphocytic|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PDE3B SLC4A4 KIR3DL1

4.93e-04177393395f005f019aabb18738d3a10a04c37f216deda3
ToppCellfacs-Skin-Anagen-3m-Lymphocytic-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PDE3B SLC4A4 KIR3DL1

4.93e-041773939a5bf67a801826d094f679dd2189b62296c9694f
ToppCell3'_v3-GI_small-bowel-Lymphocytic_NK|GI_small-bowel / Manually curated celltypes from each tissue

KIR2DL1 KIR2DL3 KIR3DL1

5.09e-04179393535bdfdd990ba9ee3edc8f3ad15297f8fb5a266e
ToppCell390C-Lymphocytic-ILC-ILC-1|390C / Donor, Lineage, Cell class and subclass (all cells)

GTF2IRD2B PDE3B KIR2DL1

5.09e-04179393e7045e27f0eb88f552b31c04b56d78e5ccd7a36c
ToppCellASK440-Immune-NK_cell|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq

KIR2DL1 KIR2DL2 KIR3DL1

5.18e-04180393340e750356d23fe9af0e8f298f8a273ff426052f
ToppCell3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-NK_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

KIR2DL1 KIR2DL3 KIR3DL1

5.18e-04180393512c005567ad9c78cc5cc83862fc1219bcf49f60
ComputationalNeighborhood of IL2RB

KIR3DL3 KIR2DS2 KIR2DL1 KIR3DL1

1.35e-0646204GNF2_IL2RB
DrugD-Au

KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

4.30e-0977406CID000277822
DrugAa1

KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1

6.79e-0983406CID009549188
Drugpristane

GTF2IRD2 KIR3DL3 GTF2IRD2B KIR2DL2 KIR2DL3 KIR2DS5

2.55e-07152406CID000015979
Drugglycoluril

KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1

2.25e-0653404CID000062347
DrugAb-9

KIR2DL2 KIR2DL3 KIR3DL1

6.54e-0621403CID006540280
Drug6-carboxyfluorescein diacetate

KIR2DL1 KIR2DL2 KIR2DL3

1.97e-0530403CID000151095
Drug1xa5

KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3

2.13e-0593404CID000157684
DrugNSC237521

KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 CX3CL1

3.22e-05210405CID000428410
DrugAC1L8NTU

KIR2DL2 KIR2DL3 SLC4A4 CX3CL1

3.84e-05108404CID000384608
DrugAC1L1AQK

KIR3DL3 KIR2DL2 KIR2DL3 KIR2DS5

5.61e-05119404CID000001105
Drugacyclovir

KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1

6.58e-05124404CID000002022
Drug1c88

KIR3DL3 KIR2DL2 KIR2DL3 KIR2DS5

7.00e-05126404CID000444766
DrugAGN 1135

KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1

1.08e-04141404CID000122316
Diseaselevel of killer cell immunoglobulin-like receptor 2DS2 in blood serum

KIR3DL3 KIR2DL1 KIR2DL3

2.13e-093393OBA_2042107
Diseasekiller cell immunoglobulin-like receptor 2DS2 measurement

KIR3DL3 KIR2DL1 KIR2DL3

9.61e-0715393EFO_0801746
Diseaselung disease severity measurement

GPR32 GPR32P1 SOAT2

5.13e-04118393EFO_0007744
Diseaselevel of Sphingomyelin (d38:1) in blood serum

SLC4A4 CERS4

7.23e-0430392OBA_2045180
DiseaseParkinsonism (biomarker_via_orthology)

ABCC9 CX3CL1

9.30e-0434392DOID:0080855 (biomarker_via_orthology)
DiseaseParkinson disease, disease progression measurement

GPR32 GPR32P1

1.22e-0339392EFO_0008336, MONDO_0005180
Diseasevitamin D measurement, COVID-19

PDE3B SLC4A4

1.92e-0349392EFO_0004631, MONDO_0100096
Diseasestem Cell Growth Factor beta measurement

PIEZO2 GPR32P1

4.44e-0375392EFO_0008292

Protein segments in the cluster

PeptideGeneStartEntry
LLQLLHVFWSCLILR

CERS4

311

Q9HA82
WLCLHSVALISRTFL

ABCD2

106

Q9UBJ2
WLLAAALCSAHLKFR

GPR32

166

O75388
LLLLWLAASCSLFLH

ADCY4

746

Q8NFM4
LRWILTFALLFVHVC

ABCC9

71

O60706
LFFLLHRWCSNKKNA

KIR2DS2

261

P43631
LHTLIFLACSNFWFK

LRRC8A

131

Q8IWT6
LVAFLFCILWSLLFH

PGAP2

31

Q9UHJ9
LFILLFFLLHRWCSN

KIR2DL2

256

P43627
KRWCTQILSALSFLH

NRBP2

151

Q9NSY0
LFILLLFFLLHRWCC

KIR2DL3

256

P43628
LFLCLLWAALRTTLF

GPR137C

86

Q8N3F9
LFILLLFFLLHLWCS

KIR3DL1

351

P43629
LFFLLHLWCSNKKNA

KIR3DL1

356

P43629
TNSCHLYLWLFLLLL

PCNX2

31

A6NKB5
LLCIWKLLVSFHDRK

ITGB6

726

P18564
LRHCVLVLLLASFVW

PDE3B

216

Q13370
AILLFFLLHRWCANK

KIR3DL3

336

Q8N743
LLHTLIFAACSNFWL

LRRC8B

126

Q6P9F7
LFFLLHRWCSNKKNA

KIR2DS5

261

Q14953
FCLTELHLWSLKNTL

WDPCP

36

O95876
HKQRLLFSCLLWLTF

GPR89A

106

B7ZAQ6
HKQRLLFSCLLWLTF

GPR89B

106

P0CG08
WLLAAALCSAHLKFR

GPR32P1

166

Q8NGA4
LLRFHRNSKWTLQCL

FSCN3

96

Q9NQT6
KHFFSLSWFCGLLLL

GCRG224

16

Q8WZA8
AFLAKLCLWETHLTR

GTF2IRD2

786

Q86UP8
AFLAKLCLWETHLTR

GTF2IRD2B

786

Q6EKJ0
LFILLFFLLHRWCSN

KIR2DL1

256

P43626
VLLRWRLLHTLFCTL

MROH5

1196

Q6ZUA9
LIRFSHTFLICLASW

TAS2R38

121

P59533
LFTLLLFLKCFHWLA

SYVN1

106

Q86TM6
CWALFLNTQHILLLF

SLC47A2

126

Q86VL8
LLLIFFAFLHCWLNA

SOAT2

351

O75908
SWLLKGCLLVTLFFL

ZDHHC13

316

Q8IUH4
KILFTITFWLLLRQH

PIEZO2

586

Q9H5I5
CLKSFLERHGLSLLW

SETD2

1766

Q9BYW2
SLLLQLRQKWHSLFL

YTHDC2

1121

Q9H6S0
HLFTFLQVLCLALLW

SLC4A4

951

Q9Y6R1
NWLLTASRDHLCKLF

WDR33

301

Q9C0J8
LWKHFRAVSLCLFLL

RNF145

376

Q96MT1
NFTWCYLLRQKSLHL

HIVEP1

1941

P15822
LSWLLRLATFCHLTV

CX3CL1

6

P78423